IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 275 filers reported holding IMMUNOGEN INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,094,968 | -16.0% | 699,116 | -0.2% | 0.01% | -10.0% |
Q2 2023 | $13,215,097 | +13665.7% | 700,323 | +5300.0% | 0.01% | – |
Q4 2021 | $96,000 | +29.7% | 12,969 | 0.0% | 0.00% | – |
Q3 2021 | $74,000 | -25.3% | 12,969 | -13.4% | 0.00% | – |
Q2 2021 | $99,000 | -41.8% | 14,982 | -28.5% | 0.00% | – |
Q1 2021 | $170,000 | +146.4% | 20,944 | +96.8% | 0.00% | – |
Q4 2020 | $69,000 | -95.5% | 10,643 | -90.6% | 0.00% | -100.0% |
Q4 2015 | $1,541,000 | +40.9% | 113,550 | -0.3% | 0.00% | +100.0% |
Q3 2015 | $1,094,000 | -27.4% | 113,927 | +8.7% | 0.00% | -50.0% |
Q2 2015 | $1,507,000 | +77.7% | 104,829 | +30.9% | 0.00% | +100.0% |
Q3 2014 | $848,000 | -5.8% | 80,058 | +5.4% | 0.00% | 0.0% |
Q2 2014 | $900,000 | +14.4% | 75,984 | +44.2% | 0.00% | 0.0% |
Q1 2014 | $787,000 | -5.6% | 52,680 | -7.4% | 0.00% | 0.0% |
Q4 2013 | $834,000 | -13.6% | 56,880 | +0.3% | 0.00% | 0.0% |
Q3 2013 | $965,000 | +9.4% | 56,710 | +6.7% | 0.00% | 0.0% |
Q2 2013 | $882,000 | – | 53,160 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 10,906,962 | $69,914,000 | 3.04% |
Fernwood Investment Management, LLC | 224,500 | $1,439,000 | 0.77% |
Telemetry Investments, L.L.C. | 272,000 | $1,744,000 | 0.66% |
Schonfeld Strategic Advisors LLC | 865,356 | $5,547,000 | 0.45% |
Virtus ETF Advisers LLC | 53,977 | $346,000 | 0.43% |
Endurant Capital Management LP | 210,800 | $1,351,000 | 0.41% |
SPHERA FUNDS MANAGEMENT LTD. | 500,000 | $3,205,000 | 0.38% |
TWIN FOCUS CAPITAL PARTNERS, LLC | 113,216 | $726,000 | 0.37% |
Orbimed Advisors | 2,834,126 | $18,167,000 | 0.23% |
PINNACLE ASSOCIATES LTD | 1,322,231 | $8,476,000 | 0.16% |